Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

Stemler J, Yeghiazaryan L, Stephan C, Greve-Isdahl Mohn K, Cox RJ, Carcas-Sansuan AJ, Romero Rodriguez E, Moltó J, Vergara Mitxeltorena I, Pink I, Welte T, Zablockienė B, Akova M, Bethe U, Grimm S, Salmanton-García J, Jakobs J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA, EU-COVAT-1 AGED study group on behalf of the VACCELERATE Consortium

Open source

DOI: 10.1016/j.ijid.2026.108466
Published: 2026 Apr
Container: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijid.2026.108466,
  title = {Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.},
  author = {Stemler J and Yeghiazaryan L and Stephan C and Greve-Isdahl Mohn K and Cox RJ and Carcas-Sansuan AJ and Romero Rodriguez E and Moltó J and Vergara Mitxeltorena I and Pink I and Welte T and Zablockienė B and Akova M and Bethe U and Grimm S and Salmanton-García J and Jakobs J and Tischmann L and Zarrouk M and Cüppers A and Biehl LM and Grothe J and Mellinghoff SC and Nacov JA and Neuhann JM and Sprute R and Frías-Iniesta J and Negi R and Gaillard C and Saini G and León AG and Mallon PWG and Lammens C and Hotterbeekx A and Loens K and Malhotra-Kumar S and Goossens H and Kumar-Singh S and König F and Posch M and Koehler P and Cornely OA and EU-COVAT-1 AGED study group on behalf of the VACCELERATE Consortium},
  year = {2026},
  journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  doi = {10.1016/j.ijid.2026.108466},
  url = {https://doi.org/10.1016/j.ijid.2026.108466}
}

RIS

TY  - JOUR
TI  - Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.
AU  - Stemler J
AU  - Yeghiazaryan L
AU  - Stephan C
AU  - Greve-Isdahl Mohn K
AU  - Cox RJ
AU  - Carcas-Sansuan AJ
AU  - Romero Rodriguez E
AU  - Moltó J
AU  - Vergara Mitxeltorena I
AU  - Pink I
AU  - Welte T
AU  - Zablockienė B
AU  - Akova M
AU  - Bethe U
AU  - Grimm S
AU  - Salmanton-García J
AU  - Jakobs J
AU  - Tischmann L
AU  - Zarrouk M
AU  - Cüppers A
AU  - Biehl LM
AU  - Grothe J
AU  - Mellinghoff SC
AU  - Nacov JA
AU  - Neuhann JM
AU  - Sprute R
AU  - Frías-Iniesta J
AU  - Negi R
AU  - Gaillard C
AU  - Saini G
AU  - León AG
AU  - Mallon PWG
AU  - Lammens C
AU  - Hotterbeekx A
AU  - Loens K
AU  - Malhotra-Kumar S
AU  - Goossens H
AU  - Kumar-Singh S
AU  - König F
AU  - Posch M
AU  - Koehler P
AU  - Cornely OA
AU  - EU-COVAT-1 AGED study group on behalf of the VACCELERATE Consortium
PY  - 2026
JO  - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
DO  - 10.1016/j.ijid.2026.108466
UR  - https://doi.org/10.1016/j.ijid.2026.108466
ER  -

APA

J, S., L, Y., C, S., K, G. M., RJ, C., AJ, C., E, R. R., J, M., I, V. M., I, P., T, W., B, Z., M, A., U, B., S, G., J, S., J, J., L, T., M, Z., A, C., LM, B., J, G., SC, M., JA, N., JM, N., R, S., J, F., R, N., C, G., G, S., AG, L., PWG, M., C, L., A, H., K, L., S, M., H, G., S, K., F, K., M, P., P, K., OA, C., & Consortium, E. A. S. G. O. B. O. T. V. (2026). Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2026.108466

Source records

pubmed · retrieved 2026-09-25T18:20:05.537Z